Evolus (EOLS) Revenue (2019 - 2026)
Evolus (EOLS) reported Revenue of $73.1 million for Q1 2026, up 6.74% on a YoY basis from $68.5 million in Q1 2025, and down 19.01% quarter-over-quarter from $90.3 million in Q4 2025.
Evolus (EOLS) Revenue (2019 - 2026) Analysis & Trends
Evolus has reported Revenue for 8 years, with the latest figure at $73.1 million in Q1 2026.
- For the quarter ending Q1 2026, Revenue rose 6.74% year-over-year to $73.1 million; the trailing twelve-month figure through Mar 2026 stood at $301.8 million (up 9.56% YoY), and the FY2025 full-year result was $297.2 million, up 11.61% from the prior year.
- Revenue for Q1 2026 stood at $73.1 million, down from $90.3 million in the prior quarter.
- The five-year high for Revenue was $90.3 million in Q4 2025, with the low at $33.9 million in Q3 2022.
- Historically, Revenue has averaged $58.1 million across 5 years, with a median of $61.0 million in 2023.
- Annual changes were most pronounced in 2022 — Revenue jumped 177.0% — and 2025, when it rose 3.7%.
- Evolus' Revenue stood at $43.6 million in 2022, then jumped by 39.76% to $61.0 million in 2023, then climbed by 29.42% to $78.9 million in 2024, then gained by 14.38% to $90.3 million in 2025, then decreased by 19.01% to $73.1 million in 2026.
- The last three Revenue figures came in at $73.1 million (Q1 2026), $90.3 million (Q4 2025), and $69.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 3.98 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 2.26 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 781.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 67.54 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 814.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1.37 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 39.50 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 377.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 608.10 Mn |
| 10 | Evolus | 435.45 Mn | 385.65 Mn | 48.90 Mn | 73.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 73.14 Mn |
| Dec 31, 2025 | 90.30 Mn |
| Sep 30, 2025 | 68.97 Mn |
| Jun 30, 2025 | 69.39 Mn |
| Mar 31, 2025 | 68.52 Mn |
| Dec 31, 2024 | 78.95 Mn |
| Sep 30, 2024 | 61.09 Mn |
| Jun 30, 2024 | 66.91 Mn |
| Mar 31, 2024 | 59.33 Mn |
| Dec 31, 2023 | 61.00 Mn |
| Sep 30, 2023 | 50.02 Mn |
| Jun 30, 2023 | 49.35 Mn |
| Mar 31, 2023 | 41.72 Mn |
| Dec 31, 2022 | 43.65 Mn |
| Sep 30, 2022 | 33.90 Mn |
| Jun 30, 2022 | 37.16 Mn |
| Mar 31, 2022 | 33.91 Mn |
| Dec 31, 2021 | 34.66 Mn |
| Sep 30, 2021 | 26.68 Mn |
| Jun 30, 2021 | 26.10 Mn |